From multi-omics approaches to precision medicine in amyotrophic lateral sclerosis

G Morello, S Salomone, V D'Agata… - Frontiers in …, 2020 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a devastating and fatal neurodegenerative disorder,
caused by the degeneration of upper and lower motor neurons for which there is no truly …

A Diagnostic Gene-Expression Signature in Fibroblasts of Amyotrophic Lateral Sclerosis

G Morello, V La Cognata, M Guarnaccia, V La Bella… - Cells, 2023 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a fatal, progressive neurodegenerative disease with
limited treatment options. Diagnosis can be difficult due to the heterogeneity and non …

[PDF][PDF] A Diagnostic Gene-Expression Signature in Fibroblasts of Amyotrophic Lateral Sclerosis. Cells 2023, 12, 1884

G Morello, V La Cognata, M Guarnaccia, V La Bella… - 2023 - researchgate.net
Amyotrophic lateral sclerosis (ALS) is a fatal, progressive neurodegenerative disease with
limited treatment options. Diagnosis can be difficult due to the heterogeneity and non …

[HTML][HTML] Translational medicine in neurological disorders: a genomic perspective

G Gentile, S Cavallaro - Current genomics, 2019 - ncbi.nlm.nih.gov
According to the European Society for Translational Medicine (TM), this interdisciplinary
branch of biomedical field was established on three pillars: benchside, bedside and …